You are here

“Genome Engineering to Advance Regenerative Medicine”

Bruce Conklin, PhD—Senior Investigator
  • Science for Admin
Monday, October 19, 2015 - 12:00pm
Room 107C/D

Bruce Conklin’s laboratory, established at Gladstone in 1995, studies the mechanisms by which hormonal signals direct the development and function of complex tissues, including those that control the heart. The focus of his research is on the largest known family of receptors for hormones and drugs, the G protein-coupled receptors, which include over 700 human genes. His research focuses on disease-specific stem cells that provide a platform for determining if specific signaling pathways can be used to find new medicines.

His laboratory focuses on human genetics that lead to cardiovascular diseases, such as cardiac arrhythmias and cardiomyopathy. Their model system is induced pluripotent (iPS) cells derived from patients with specific diseases, as well as iPS cells that we engineer to test the role of defined genetic changes on disease. They use human iPS cells to create cardiovascular disease models to better understand basic disease mechanisms and reveal pharmacology approaches (i.e., drugs) to treat those diseases. The Conklin laboratory has a long-standing interest in pharmacology and cellular engineering that allows us to take new approaches to disease modeling to open new avenues for biological investigation and develop novel therapeutic strategies.

Hosted By: 


For nearly 25 years, Science for Admin has given Gladstone administrators the opportunity to learn firsthand about the science they enable. View all upcoming Science for Admin Events


Upcoming Events

Ruwanthi Gunawardane, PhD
Mon, Sep 23, 2019 - 3:00pm
Sara Sawyer, PhD, University of Colorado Boulder
Tue, Sep 24, 2019 - 2:00pm
David Schaffer, PhD
Mon, Sep 30, 2019 - 3:00pm